- call +1-201-465-4211
- email sales@mrinsights.biz
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Scope of the Report:
The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Pimozide includes 1Mg, 2Mg, 4Mg, and the proportion of 2Mg in 2017 is about 53%.
Pimozide is widely used in hospitals, drugstores and other places. The most proportion of Pimozide is used for hospitals in 2017 is 54%.
The worldwide market for Pimozide is expected to grow at a CAGR of roughly -1.1% over the next five years, will reach 11 million US$ in 2024, from 12 million US$ in 2019, according to a new study.
This report focuses on the Pimozide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
1Mg
2Mg
4Mg
Market Segment by Applications, can be divided into
Hospitals
Drugstores
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pimozide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pimozide, with price, sales, revenue and global market share of Pimozide in 2017 and 2018.
Chapter 3, the Pimozide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pimozide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pimozide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pimozide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pimozide Introduction
1.2 Market Analysis by Type
1.2.1 1Mg
1.2.2 2Mg
1.2.3 4Mg
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Drugstores
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Pimozide Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Par Pharmaceutical
2.2.1 Business Overview
2.2.2 Pimozide Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Par Pharmaceutical Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Pimozide Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Eumedica
2.4.1 Business Overview
2.4.2 Pimozide Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eumedica Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pharmascience
2.5.1 Business Overview
2.5.2 Pimozide Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pharmascience Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Domina Pharmaceuticals
2.6.1 Business Overview
2.6.2 Pimozide Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Domina Pharmaceuticals Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Aa Pharma
2.7.1 Business Overview
2.7.2 Pimozide Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Aa Pharma Pimozide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pimozide Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Pimozide Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Pimozide Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Pimozide Manufacturer Market Share in 2018
3.3.2 Top 6 Pimozide Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Pimozide Market Analysis by Regions
4.1 Global Pimozide Sales, Revenue and Market Share by Regions
4.1.1 Global Pimozide Sales and Market Share by Regions (2014-2019)
4.1.2 Global Pimozide Revenue and Market Share by Regions (2014-2019)
4.2 North America Pimozide Sales and Growth Rate (2014-2019)
4.3 Europe Pimozide Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Pimozide Sales and Growth Rate (2014-2019)
4.5 South America Pimozide Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Pimozide Sales and Growth Rate (2014-2019)
5 North America Pimozide by Country
5.1 North America Pimozide Sales, Revenue and Market Share by Country
5.1.1 North America Pimozide Sales and Market Share by Country (2014-2019)
5.1.2 North America Pimozide Revenue and Market Share by Country (2014-2019)
5.2 United States Pimozide Sales and Growth Rate (2014-2019)
5.3 Canada Pimozide Sales and Growth Rate (2014-2019)
5.4 Mexico Pimozide Sales and Growth Rate (2014-2019)
6 Europe Pimozide by Country
6.1 Europe Pimozide Sales, Revenue and Market Share by Country
6.1.1 Europe Pimozide Sales and Market Share by Country (2014-2019)
6.1.2 Europe Pimozide Revenue and Market Share by Country (2014-2019)
6.2 Germany Pimozide Sales and Growth Rate (2014-2019)
6.3 UK Pimozide Sales and Growth Rate (2014-2019)
6.4 France Pimozide Sales and Growth Rate (2014-2019)
6.5 Russia Pimozide Sales and Growth Rate (2014-2019)
6.6 Italy Pimozide Sales and Growth Rate (2014-2019)
7 Asia-Pacific Pimozide by Country
7.1 Asia-Pacific Pimozide Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Pimozide Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Pimozide Revenue and Market Share by Country (2014-2019)
7.2 China Pimozide Sales and Growth Rate (2014-2019)
7.3 Japan Pimozide Sales and Growth Rate (2014-2019)
7.4 Korea Pimozide Sales and Growth Rate (2014-2019)
7.5 India Pimozide Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Pimozide Sales and Growth Rate (2014-2019)
8 South America Pimozide by Country
8.1 South America Pimozide Sales, Revenue and Market Share by Country
8.1.1 South America Pimozide Sales and Market Share by Country (2014-2019)
8.1.2 South America Pimozide Revenue and Market Share by Country (2014-2019)
8.2 Brazil Pimozide Sales and Growth Rate (2014-2019)
8.3 Argentina Pimozide Sales and Growth Rate (2014-2019)
8.4 Colombia Pimozide Sales and Growth Rate (2014-2019)
9 Middle East and Africa Pimozide by Countries
9.1 Middle East and Africa Pimozide Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Pimozide Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Pimozide Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Pimozide Sales and Growth Rate (2014-2019)
9.3 Turkey Pimozide Sales and Growth Rate (2014-2019)
9.4 Egypt Pimozide Sales and Growth Rate (2014-2019)
9.5 Nigeria Pimozide Sales and Growth Rate (2014-2019)
9.6 South Africa Pimozide Sales and Growth Rate (2014-2019)
10 Global Pimozide Market Segment by Type
10.1 Global Pimozide Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Pimozide Sales and Market Share by Type (2014-2019)
10.1.2 Global Pimozide Revenue and Market Share by Type (2014-2019)
10.2 1Mg Sales Growth and Price
10.2.1 Global 1Mg Sales Growth (2014-2019)
10.2.2 Global 1Mg Price (2014-2019)
10.3 2Mg Sales Growth and Price
10.3.1 Global 2Mg Sales Growth (2014-2019)
10.3.2 Global 2Mg Price (2014-2019)
10.4 4Mg Sales Growth and Price
10.4.1 Global 4Mg Sales Growth (2014-2019)
10.4.2 Global 4Mg Price (2014-2019)
11 Global Pimozide Market Segment by Application
11.1 Global Pimozide Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Drugstores Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Pimozide Market Forecast (2019-2024)
12.1 Global Pimozide Sales, Revenue and Growth Rate (2019-2024)
12.2 Pimozide Market Forecast by Regions (2019-2024)
12.2.1 North America Pimozide Market Forecast (2019-2024)
12.2.2 Europe Pimozide Market Forecast (2019-2024)
12.2.3 Asia-Pacific Pimozide Market Forecast (2019-2024)
12.2.4 South America Pimozide Market Forecast (2019-2024)
12.2.5 Middle East and Africa Pimozide Market Forecast (2019-2024)
12.3 Pimozide Market Forecast by Type (2019-2024)
12.3.1 Global Pimozide Sales Forecast by Type (2019-2024)
12.3.2 Global Pimozide Market Share Forecast by Type (2019-2024)
12.4 Pimozide Market Forecast by Application (2019-2024)
12.4.1 Global Pimozide Sales Forecast by Application (2019-2024)
12.4.2 Global Pimozide Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pimozide Picture
Table Product Specifications of Pimozide
Figure Global Sales Market Share of Pimozide by Types in 2018
Table Pimozide Types for Major M
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
